Filing Details

Accession Number:
0000950170-24-036573
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-26 17:15:10
Reporting Period:
2024-03-25
Accepted Time:
2024-03-26 17:15:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1813814 Mind Medicine (Mindmed) Inc. MNMD Medicinal Chemicals & Botanical Products (2833) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1897618 Dan Karlin C/O Mind Medicine (Mindmed) Inc.
One World Trade Center, Suite 8500
New York NY 10007
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2024-03-25 6,578 $9.50 358,452 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections under a Rule 10b5-1 plan adopted on June 14, 2022.
  2. The reported price is a weighted average sales price. These shares were sold in multiple transactions on March 25, 2024 at prices ranging from $9.37 to $9.55. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.